How can you advise patients taking ruxolitinib for vitiligo on looking for signs of repigmentation?
Featuring Cheri Frey, MD |
Assistant Professor, Dermatology & Residency Program Director
Director of Cosmetic Dermatology
Howard University
Washington, DC
Related CME
Related Media
Powered by Polaris TM